Details for New Drug Application (NDA): 019005
✉ Email this page to a colleague
NDA 019005 describes BRETYLIUM TOSYLATE IN DEXTROSE 5%, which is a drug marketed by Abbott, B Braun, Baxter Hlthcare, and Hospira Inc, and is included in four NDAs. Additional details are available on the BRETYLIUM TOSYLATE IN DEXTROSE 5% profile page.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
Summary for 019005
| Tradename: | BRETYLIUM TOSYLATE IN DEXTROSE 5% |
| Applicant: | Abbott |
| Ingredient: | bretylium tosylate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019005
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 800MG/100ML | ||||
| Approval Date: | Apr 29, 1986 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 200MG/100ML | ||||
| Approval Date: | Apr 29, 1986 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 400MG/100ML | ||||
| Approval Date: | Apr 29, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
